Enhanced RHO ‐ ROCK signaling is associated with CRELD2 production and fibroblast recruitment in cutaneous squamous cell carcinoma
Cytoskeleton · 2024
DOI: 10.1002/cm.21894 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytoskeleton, 2024. Verfasst von Alexandra Pittar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Biology, an Alliance between SA Pathology and the University of South Australia, Adelaide, Australia. Hauptthemen laut MEDLINE: rho-Associated Kinases, Carcinoma, Squamous Cell, Signal Transduction, Skin Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Australian Research Council, Cancer Council SA's Beat Cancer Project.
Abstract (Originalsprache)
A key characteristic of cancer cells is their ability to induce changes in their microenvironment that render it permissive to tumor growth, invasion and metastasis. Indeed, these changes are required for tumor progression. Consequently, the tumor microenvironment is emerging as a key source of new targets against cancer, with novel therapies aimed at reversing tumor‐promoting changes, reinstating a tumor‐hostile microenvironment and suppressing disease progression. RHO‐ROCK signaling, and consequent tension within the cellular actomyosin cytoskeleton, regulates a paracrine signaling cascade that establishes a tumor‐promoting microenvironment. Here, we show that consistent with our observations in breast cancer, enhanced ROCK activity and consequent production of CRELD2 is associated with the recruitment and tumor‐promoting polarization of cancer‐associated fibroblasts in cutaneous squamous cell carcinoma. Our observations provide support for the notion that the role of RHO‐ROCK signaling in establishing a tumor‐promoting microenvironment may be conserved across patients and potentially also different cancer types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Cancer Biology, an Alliance between SA Pathology and the University of South Australia, Adelaide, Australia.
- Division of Surgical Pathology, SA Pathology, Adelaide, Australia.
- Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia.
- Basil Hetzel Institute for Translational Health Research, Woodville South, Adelaide, Australia.
ORCID-Profile: Alexandra Pittar, Edward J Buckley, Sarah T Boyle, Michael S Samuel
Förderung
- National Health and Medical Research Council
- Australian Research Council
- Cancer Council SA's Beat Cancer Project
- Royal Adelaide Hospital Research Fund
- Hospital Research Foundation
Zitieren
APA
Pittar, A., Buckley, E. J., Boyle, S. T., Ibbetson, S. J., & Samuel, M. S. (2024). Enhanced RHO ‐ ROCK signaling is associated with CRELD2 production and fibroblast recruitment in cutaneous squamous cell carcinoma. Cytoskeleton. https://doi.org/10.1002/cm.21894
Vancouver
Pittar A, Buckley EJ, Boyle ST, Ibbetson SJ, Samuel MS. Enhanced RHO ‐ ROCK signaling is associated with CRELD2 production and fibroblast recruitment in cutaneous squamous cell carcinoma. Cytoskeleton. 2024. doi:10.1002/cm.21894
BibTeX
@article{Pittar2024,
author = {Pittar, Alexandra and Buckley, Edward J and Boyle, Sarah T and Ibbetson, S Jan and Samuel, Michael S},
title = {Enhanced RHO ‐ ROCK signaling is associated with CRELD2 production and fibroblast recruitment in cutaneous squamous cell carcinoma},
journal = {Cytoskeleton},
year = {2024},
doi = {10.1002/cm.21894}
}
EUVIMED